Steve Kirsch: Difference between revisions
Scope creep (talk | contribs) →Career: Removed dead ref, left cn |
Scope creep (talk | contribs) →Career: Doesn't appeat to MEDRS compliant, has been barely watched. |
||
| Line 24: | Line 24: | ||
In April 2020, he started the COVID-19 Early Treatment Fund (CETF) with a personal donation of $1M in order to fund [[COVID-19 drug repurposing research]].<ref>{{cite web|url=http://www.treatearly.org|title=COVID-19 Early Treatment Fund|publisher=treatearly.org|date=2020-04-14 |access-date=2020-12-22}}</ref> |
In April 2020, he started the COVID-19 Early Treatment Fund (CETF) with a personal donation of $1M in order to fund [[COVID-19 drug repurposing research]].<ref>{{cite web|url=http://www.treatearly.org|title=COVID-19 Early Treatment Fund|publisher=treatearly.org|date=2020-04-14 |access-date=2020-12-22}}</ref> |
||
Kirsch appeared in a YouTube video posted in June 2021 with [[Bret_Weinstein|Bret Weinstein]] and [[Robert W. Malone]] (the inventor of the mRNA technology) discussing the Covid-19 vaccines. <ref>{{cite web |url=https://rumble.com/vipw5h-spike-proteinmrna-is-very-dangerous-its-cytotoxic-robert-malone-steve-kirsc.html |title=Spike protein(mRNA) is very dangerous, it's cytotoxic (Robert Malone, Steve Kirsch, Bret Weinstein) |date=June 18, 2021}}</ref> |
|||
==References== |
==References== |
||
Revision as of 08:05, 10 August 2021
 | A major contributor to this article appears to have a close connection with its subject. |
Steven T. Kirsch | |
|---|---|
 | |
| Born | December 24, 1956 |
| Alma mater | Massachusetts Institute of Technology |
| Known for | Inventing the optical mouse, FrameMaker, founder of Infoseek |
Steven Todd Kirsch (born December 24, 1956) is an American serial entrepreneur who has started seven companies: Mouse Systems, Frame Technology Corp., Infoseek, Propel, Abaca, OneID, Token, and M10. He invented and patented an early version of the optical mouse. In 2007, his personal fortune was estimated at $230 million, the majority earned from the IPO of Infoseek and the acquisition of Frame Technology.[1]
Career
Kirsch has a Bachelor of Science and a Master of Science in electrical engineering and computer science from the Massachusetts Institute of Technology.[2]
In 2003, Hillary Clinton presented Kirsch with a National Caring Award from the Caring Institute in Washington, D.C.[citation needed] In 2005 he founded Abaca, which made a spam filter (99.99% accurate according to two reviews).[3][4] Abaca was acquired by Proofpoint, Inc. in 2013.[5]
On August 11, 2007, Kirsch announced on his personal Web site that he had been diagnosed with Waldenström's macroglobulinemia, a rare blood cancer.[6]
In September 2011, he started OneID[7] which is creating a user-centric Internet-scale digital identity system that uses public key cryptography to replace usernames and passwords with a single, stable, secure, digital identity that preserves privacy and is compatible with the NSTIC[8] goals.[9] The technology was used by Salsa Labs in 2013, to increase the frequency and security of online donations.[10]
In April 2020, he started the COVID-19 Early Treatment Fund (CETF) with a personal donation of $1M in order to fund COVID-19 drug repurposing research.[11]
References
- ^ a b Markoff, John (December 3, 2007). "Spam's End? Maybe, if Time Allows". Nytimes.com.
- ^ "Kirsch Foundation: About The Founders". Kirschfoundation.org. Retrieved July 11, 2011.
- ^ "Tolly Group Review of Abaca" (PDF). Tolly Group. Retrieved 22 September 2011.
- ^ "Spam Star" (PDF). Network Computing. Retrieved 22 September 2011.
- ^ "Proofpoint, Inc. Acquires Abaca Technology Corporation" (Press release). July 25, 2013. Retrieved June 20, 2021.
- ^ Diana Kapp (February 22, 2011). "The one problem he can't solve". San Francisco Magazine. Retrieved January 17, 2017.
- ^ "oneid.com". oneid.com. 2012-06-14. Retrieved 2012-06-18.
- ^ "National Strategy for Trusted Identities in Cyberspace". Nist.gov. Retrieved 2012-06-18.
- ^ Hardy, Quentin (2011-11-03). "OneID Aims to Unite Devices to Fight Hackers". The New York Times. Retrieved 3 November 2011.
- ^ "Salsa Labs Launches Quick Donate". Salsa Labs. Retrieved 26 August 2014.
- ^ "COVID-19 Early Treatment Fund". treatearly.org. 2020-04-14. Retrieved 2020-12-22.